quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:25:21·668d
INSIDERFiling
AVROBIO Inc. logo

SEC Form 4 filed by Chief Business Officer Schwabish Marc

AVRO· AVROBIO Inc.
Health Care
Original source

Companies

  • AVRO
    AVROBIO Inc.
    Health Care

Recent analyst ratings

  • Dec 18UpdateMizuho-
  • Jan 6UpdateMizuho$6.00
  • Jan 5UpdateBarclays$6.00
  • Jan 5UpdateMorgan Stanley$3.00
  • Jan 5UpdateBTIG-
  • Jan 5UpdateNeedham$8.00

Related

  • 13D/G667d
    SEC Form SC 13D filed by AVROBIO Inc.
  • SEC667d
    AVROBIO Inc. filed SEC Form 8-K: Regulation FD Disclosure
  • 13D/G667d
    SEC Form SC 13D filed by AVROBIO Inc.
  • INSIDER667d
    Former 10% owner of AVROBIO Leonard Braden Michael acquired 433,688 shares (SEC Form 4)
  • INSIDER668d
    SEC Form 4 filed by Director Donenberg Phillip B.
  • INSIDER668d
    Director Vitorovic Stefan was granted 1,028,674 shares (SEC Form 4)
  • INSIDER668d
    SEC Form 3 filed by new insider Vitorovic Stefan
  • INSIDER668d
    Director Tipirneni Praveen P. was granted 3,037 shares (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022